Innate Pharma (IPHYF) Pension (2017 - 2025)

Innate Pharma's Pension history spans 9 years, with the latest figure at $2.2 million for Q4 2025.

  • For Q4 2025, Pension fell 23.27% year-over-year to $2.2 million; the TTM value through Dec 2025 reached $2.2 million, down 23.27%, while the annual FY2025 figure was $2.2 million, 24.24% down from the prior year.
  • Pension reached $2.2 million in Q4 2025 per IPHYF's latest filing, down from $2.9 million in the prior quarter.
  • In the past five years, Pension ranged from a high of $3.4 million in Q4 2021 to a low of $2.2 million in Q4 2025.
  • Average Pension over 5 years is $2.8 million, with a median of $2.6 million recorded in 2023.
  • Peak YoY movement for Pension: crashed 31.66% in 2021, then rose 11.08% in 2024.
  • A 5-year view of Pension shows it stood at $3.4 million in 2021, then fell by 23.56% to $2.6 million in 2022, then grew by 0.95% to $2.6 million in 2023, then grew by 11.08% to $2.9 million in 2024, then fell by 23.27% to $2.2 million in 2025.
  • Per Business Quant, the three most recent readings for IPHYF's Pension are $2.2 million (Q4 2025), $2.9 million (Q4 2024), and $2.6 million (Q4 2023).